Revance Therapeutics

Ebitda 更改 日
ALKERMES USD 68.51M 189.7M 2023-09
Eli Lilly USD 3.84B 1.88B 2023-09
Neurocrine Biosciences USD 146.7M 68M 2023-09
Pacira USD 52.49M 12.98M 2023-12
Supernus Pharmaceuticals USD 40.87M 10.87M 2023-12



Revance Therapeutics - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.